Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

PLXPLX
7 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in PROTALIX BIOTHERAPEUTICS INC

JPMORGAN CHASE & CO holds 132,991 shares of PLX (PROTALIX BIOTHERAPEUTICS INC), worth $312,529 as of 2026-Q2. The position was increased (+319.7% shares).

Current Value

$312,529

Current Shares

132,991

Total Value Change

+$309,530

Total Shares Change

+131,396

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
132,991
+319.7%
$312,5290.0%$2.33
26
2026-Q1
Increased
31,685
+2.6%
$66,2210.0%$2.83
15
2025-Q4
Decreased
30,874
-48.5%
$55,5740.0%$1.74
0
2025-Q3
Increased
59,982
+73.6%
$133,1600.0%$2.16
23
2025-Q2
Increased
34,545
+2065.8%
$51,1270.0%$1.54
23
2025-Q1
Unchanged
1,595
0.0%
$4,0830.0%$2.58
0
2024-Q4
New
1,595
-
$2,9990.0%$1.89
20

Other major holders of PLX: BlackRock, Inc., BlackRock Finance, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used